Cited by 65

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Modeling Late-Onset Sporadic Alzheimer’s Disease through BMI1 Deficiency

Flamier, Anthony, El Hajjar, Jida, Adjaye, James, Fernandes, Karl J., Abdouh, Mohamed, Bernier, Gilbert·2018·Cell Reports

Abstract

Late-onset sporadic Alzheimer's disease (AD) is the most prevalent form of dementia, but its origin remains poorly understood. The Bmi1/Ring1 protein complex maintains transcriptional repression of developmental genes through histone H2A mono-ubiquitination, and Bmi1 deficiency in mice results in growth retardation, progeria, and neurodegeneration. Here, we demonstrate that BMI1 is silenced in AD brains, but not in those with early-onset familial AD, frontotemporal dementia, or Lewy body dementia. BMI1 expression was also reduced in cortical neurons from AD patient-derived induced pluripotent stem cells but not in neurons overexpressing mutant APP and PSEN1. BMI1 knockout in human post-mitotic neurons resulted in amyloid beta peptide secretion and deposition, p-Tau accumulation, and neurodegeneration. Mechanistically, BMI1 was required to repress microtubule associated protein tau (MAPT) transcription and prevent GSK3beta and p53 stabilization, which otherwise resulted in neurodegeneration. Restoration of BMI1 activity through genetic or pharmaceutical approaches could represent a therapeutic strategy against AD.

Overview

Integrity signals

Registry

Crossref · 10.1016/j.celrep.2018.04.097

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 39

  1. Abdouh, 2009, BMI1 sustains human glioblastoma multiforme stem cell renewal, J. Neurosci., 29, 8884, 10.1523/JNEUROSCI.0968-09.2009 · DOI
  2. Alonso, 1996, Alzheimer’s disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules, Nat. Med., 2, 783, 10.1038/nm0796-783 · DOI · Paper page
  3. Anckar, 2011, Regulation of HSF1 function in the heat stress response: implications in aging and disease, Annu. Rev. Biochem., 80, 1089, 10.1146/annurev-biochem-060809-095203 · DOI
  4. Ando, 2011, N-cadherin regulates p38 MAPK signaling via association with JNK-associated leucine zipper protein: implications for neurodegeneration in Alzheimer disease, J. Biol. Chem., 286, 7619, 10.1074/jbc.M110.158477 · DOI · Paper page
  5. Baskin, 1999, Brain choline acetyltransferase and mental function in Alzheimer disease, Arch. Neurol., 56, 1121, 10.1001/archneur.56.9.1121 · DOI
  6. Bihaqi, 2012, Do epigenetic pathways initiate late onset Alzheimer disease (LOAD): towards a new paradigm, Curr. Alzheimer Res., 9, 574, 10.2174/156720512800617982 · DOI
  7. Blennow, 2006, Alzheimer’s disease, Lancet, 368, 387, 10.1016/S0140-6736(06)69113-7 · DOI · Paper page
  8. Buchwald, 2006, Structure and E3-ligase activity of the Ring-Ring complex of polycomb proteins Bmi1 and Ring1b, EMBO J., 25, 2465, 10.1038/sj.emboj.7601144 · DOI
  9. Calao, 2013, Direct effects of Bmi1 on p53 protein stability inactivates oncoprotein stress responses in embryonal cancer precursor cells at tumor initiation, Oncogene, 32, 3616, 10.1038/onc.2012.368 · DOI
  10. Chatoo, 2009, The polycomb group gene Bmi1 regulates antioxidant defenses in neurons by repressing p53 pro-oxidant activity, J. Neurosci., 29, 529, 10.1523/JNEUROSCI.5303-08.2009 · DOI
  11. Culmsee, 2005, p53 in neuronal apoptosis, Biochem. Biophys. Res. Commun., 331, 761, 10.1016/j.bbrc.2005.03.149 · DOI
  12. Dammer, 2011, Polyubiquitin linkage profiles in three models of proteolytic stress suggest the etiology of Alzheimer disease, J. Biol. Chem., 286, 10457, 10.1074/jbc.M110.149633 · DOI
  13. Espuny-Camacho, 2013, Pyramidal neurons derived from human pluripotent stem cells integrate efficiently into mouse brain circuits in vivo, Neuron, 77, 440, 10.1016/j.neuron.2012.12.011 · DOI · Paper page
  14. Facchino, 2010, BMI1 confers radioresistance to normal and cancerous neural stem cells through recruitment of the DNA damage response machinery, J. Neurosci., 30, 10096, 10.1523/JNEUROSCI.1634-10.2010 · DOI · Paper page
  15. Fraser, 2001, Presenilin function: connections to Alzheimer’s disease and signal transduction, Biochem. Soc. Symp., 89
  16. Hamilton, 2015, Aberrant Lipid Metabolism in the Forebrain Niche Suppresses Adult Neural Stem Cell Proliferation in an Animal Model of Alzheimer’s Disease, Cell Stem Cell, 17, 397, 10.1016/j.stem.2015.08.001 · DOI · Paper page
  17. Hand, 2005, Phosphorylation of Neurogenin2 specifies the migration properties and the dendritic morphology of pyramidal neurons in the neocortex, Neuron, 48, 45, 10.1016/j.neuron.2005.08.032 · DOI
  18. Hossini, 2015, Induced pluripotent stem cell-derived neuronal cells from a sporadic Alzheimer’s disease donor as a model for investigating AD-associated gene regulatory networks, BMC Genomics, 16, 84, 10.1186/s12864-015-1262-5 · DOI
  19. Ismail, 2010, BMI1-mediated histone ubiquitylation promotes DNA double-strand break repair, J. Cell Biol., 191, 45, 10.1083/jcb.201003034 · DOI · Paper page
  20. Jackson, 2002, Human wild-type tau interacts with wingless pathway components and produces neurofibrillary pathology in Drosophila, Neuron, 34, 509, 10.1016/S0896-6273(02)00706-7 · DOI · Paper page
  21. Jacobs, 1999, The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus, Nature, 397, 164, 10.1038/16476 · DOI · Paper page
  22. Kim, 2012, The heat shock transcription factor Hsf1 is downregulated in DNA damage-associated senescence, contributing to the maintenance of senescence phenotype, Aging Cell, 11, 617, 10.1111/j.1474-9726.2012.00827.x · DOI
  23. Kim, 2013, Molecular chaperone functions in protein folding and proteostasis, Annu. Rev. Biochem., 82, 323, 10.1146/annurev-biochem-060208-092442 · DOI
  24. Lambert, 2007, Monoclonal antibodies that target pathological assemblies of Abeta, J. Neurochem., 100, 23, 10.1111/j.1471-4159.2006.04157.x · DOI · Paper page
  25. Li, 2006, Structure of a Bmi-1-Ring1B polycomb group ubiquitin ligase complex, J. Biol. Chem., 281, 20643, 10.1074/jbc.M602461200 · DOI
  26. Lu, 2014, REST and stress resistance in ageing and Alzheimer’s disease, Nature, 507, 448, 10.1038/nature13163 · DOI
  27. Mano, 2017, Neuron-specific methylome analysis reveals epigenetic regulation and tau-related dysfunction of BRCA1 in Alzheimer’s disease, Proc. Natl. Acad. Sci. USA, 114, E9645, 10.1073/pnas.1707151114 · DOI
  28. Medina, 2014, New insights into the role of glycogen synthase kinase-3 in Alzheimer’s disease, Expert Opin. Ther. Targets, 18, 69, 10.1517/14728222.2013.843670 · DOI
  29. Moore, 2015, APP metabolism regulates tau proteostasis in human cerebral cortex neurons, Cell Rep., 11, 689, 10.1016/j.celrep.2015.03.068 · DOI · Paper page
  30. Pickart, 2004, Ubiquitin: structures, functions, mechanisms, Biochim. Biophys. Acta, 1695, 55, 10.1016/j.bbamcr.2004.09.019 · DOI
  31. Rovelet-Lecrux, 2010, Frontotemporal dementia phenotype associated with MAPT gene duplication, J. Alzheimers Dis., 21, 897, 10.3233/JAD-2010-100441 · DOI
  32. Rubio, 2016, Rapid and efficient CRISPR/Cas9 gene inactivation in human neurons during human pluripotent stem cell differentiation and direct reprogramming, Sci. Rep., 6, 37540, 10.1038/srep37540 · DOI
  33. Sherr, 2001, The INK4a/ARF network in tumour suppression, Nat. Rev. Mol. Cell Biol., 2, 731, 10.1038/35096061 · DOI
  34. Smith, 2015, Molecular chaperones and neuronal proteostasis, Semin. Cell Dev. Biol., 40, 142, 10.1016/j.semcdb.2015.03.003 · DOI
  35. Stokin, 2005, Axonopathy and transport deficits early in the pathogenesis of Alzheimer’s disease, Science, 307, 1282, 10.1126/science.1105681 · DOI · Paper page
  36. Takahashi, 2007, Induction of pluripotent stem cells from adult human fibroblasts by defined factors, Cell, 131, 861, 10.1016/j.cell.2007.11.019 · DOI · Paper page
  37. Tang, 2015, MEK guards proteome stability and inhibits tumor-suppressive amyloidogenesis via HSF1, Cell, 160, 729, 10.1016/j.cell.2015.01.028 · DOI
  38. Valk-Lingbeek, 2004, Stem cells and cancer; the polycomb connection, Cell, 118, 409, 10.1016/j.cell.2004.08.005 · DOI · Paper page
  39. van der Lugt, 1994, Posterior transformation, neurological abnormalities, and severe hematopoietic defects in mice with a targeted deletion of the bmi-1 proto-oncogene, Genes Dev., 8, 757, 10.1101/gad.8.7.757 · DOI

Cited by

Sorted by citations

Metadata

Authors
Flamier, A., El Hajjar, J., Adjaye, J., Fernandes, K. J., Abdouh, M., & Bernier, G.
Venue
Cell Reports
Publisher
Elsevier BV
Published
2018-05
Volume
23
Issue
9
Pages
2653-2666
ISSN
2211-1247
Cited by
65
References
11
Language
en
Funders
  • Canadian Institutes of Health Research (374972)
  • Université de Montréal

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review